• Login/Join
    • Login
    • Join Agri-TechE
Menu
  • Login/Join
    • Login
    • Join Agri-TechE
  • Home
  • About
    • About Agri-TechE
    • Stakeholder Group
    • Introductions to the agri-tech cluster
    • International
    • Agri-Tech Briefings
      • Controlled Environment Agriculture
      • Gene editing consultation – what does it mean for agri-tech?
      • Controlling light in farming
      • What is ELMs? Agri-Tech to support Environmental Land Management
    • Agri-TechE Newsletters
      • Sign up to the newsletter
  • Events
    • Upcoming Events
    • Agri-TechE activities, conferences and missions for 2022
    • REAP Conference 2022
    • Agri-Tech Week
    • Our Publications
  • Articles
    • Agri-tech News
    • Member News
    • Monthly Musings
    • Innovator Spotlight
    • Leaders in the Field
    • Agri-Tech Archives
  • Community
    • Research Digest
    • Opportunity Zone
    • Early-Career Innovators’ Forum (ECIF)
    • Funding Latest
  • Members
    • Directory
    • Become an Agri-TechE Member
    • Member Testimonials
    • Increasing your profile
    • Agri-TechE Member Drop-In
  • Contact Us
Menu
  • Home
  • About
    • About Agri-TechE
    • Stakeholder Group
    • Introductions to the agri-tech cluster
    • International
    • Agri-Tech Briefings
      • Controlled Environment Agriculture
      • Gene editing consultation – what does it mean for agri-tech?
      • Controlling light in farming
      • What is ELMs? Agri-Tech to support Environmental Land Management
    • Agri-TechE Newsletters
      • Sign up to the newsletter
  • Events
    • Upcoming Events
    • Agri-TechE activities, conferences and missions for 2022
    • REAP Conference 2022
    • Agri-Tech Week
    • Our Publications
  • Articles
    • Agri-tech News
    • Member News
    • Monthly Musings
    • Innovator Spotlight
    • Leaders in the Field
    • Agri-Tech Archives
  • Community
    • Research Digest
    • Opportunity Zone
    • Early-Career Innovators’ Forum (ECIF)
    • Funding Latest
  • Members
    • Directory
    • Become an Agri-TechE Member
    • Member Testimonials
    • Increasing your profile
    • Agri-TechE Member Drop-In
  • Contact Us

Search

More results…

Generic filters
Exact matches only

  • Member News
  • animal health, biotechnology, bovine TB, disease, innovation, PBD Biotech

Actiphage test wins UK Royal Dairy Innovation Award 2019

  • February 8, 2019
  • 2:28 pm

PBD Biotech’s novel Actiphage® testing technology was crowned winner of the Royal Dairy Innovation Award at Dairy-Tech 2019 (6 February 2019).

PBD Biotech win Royal Dairy Innovation Award 2019
Dr Berwyn Clarke of PBD Biotech is presented with the award by Princess Anne

The Royal Dairy Innovation trophy and certificate are awarded for research and development in the field of dairy farming. With the award going to the most practical, relevant product, which is likely to be the most significant innovation for the future of dairying.

Actiphage is an innovative new test for the rapid detection of bovine TB, Johne’s disease and other mycobacterial infections. It has the potential to expedite food safety checks on milk and dairy products; revolutionise livestock disease management; and ease the burden on farmers, the industry and wider public.

Receiving the award from HRH The Princess Royal, CEO of PBD Biotech Dr Berwyn Clarke said, “The dairy industry is known as an early-adopter of innovation, so we’re delighted Actiphage has been recognised amongst such a strong field of emerging tech and forward-thinking services.”

Every year, Johne’s disease costs UK farmers and industry at least £13million and an increasing number of retailers are removing suppliers from their milk pool if they are not engaged in Johne’s disease testing.

Again in the UK alone, bovine TB results in almost 44,000 cattle slaughtered annually and an estimated cost to the taxpayer of £100million.

PBD Biotech’s Actiphage fits into current animal health testing practices and is the only diagnostic able to detect live mycobacteria – differentiating between infection and vaccination – that delivers results within 6 hours.

Originally developed as a tool for diagnosis of human TB, Actiphage has been optimised and developed to provide enhanced sensitivity and specificity for use in blood or milk samples.

“Globally there is growing concern regarding the presence of live mycobacteria in milk that may have human health implications. This prestigious award is recognition of the opportunity this technology provides to ensure dairy products are free from these organisms as part of routine dairy quality control,” added Dr Clarke.

“We are seeing significant interest from dairy organisations throughout the world in Actiphage, and this award will significantly aid in transferring our technology into those global markets.”

Share

Share on facebook
Share on twitter
Share on linkedin
Related Posts
  • Actiphage is ‘additional test’ farmers want to use, says Godfray TB review
  • Heartbreak & Hope in the fight against bovine TB
  • PBD Biotech secures £2.3m funding for OIE validation of its rapid, accurate bovine TB test
  • Top innovation award for Actiphage, rapid tuberculosis test
  • As bovine TB reaches record levels in Wales permission is given for first trial of PBD Biotech’s Actiphage® blood test
Archives

Agri-TechE on Twitter

Tweets by AgriTechE 

MORE INFORMATION

  • News archive
  • Privacy
  • Events
  • Newsletter sign-up
  • View latest newsletter
Menu
  • News archive
  • Privacy
  • Events
  • Newsletter sign-up
  • View latest newsletter
Twitter Facebook Youtube Linkedin Instagram

© Agri-TechE 2022

Site design by Out of House